A detailed history of Axa S.A. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Axa S.A. holds 108,056 shares of HALO stock, worth $5.14 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
108,056
Holding current value
$5.14 Million
% of portfolio
0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$51.3 - $64.42 $5.54 Million - $6.96 Million
108,056 New
108,056 $6.18 Million
Q1 2024

May 15, 2024

BUY
$33.68 - $41.95 $2.86 Million - $3.56 Million
84,869 Added 168.61%
135,203 $5.5 Million
Q4 2023

Jul 16, 2024

SELL
$33.32 - $42.1 $2.83 Million - $3.57 Million
-84,869 Reduced 62.77%
50,334 $1.86 Million
Q4 2023

Feb 14, 2024

BUY
$33.32 - $42.1 $827,468 - $1.05 Million
24,834 Added 97.39%
50,334 $1.86 Million
Q3 2023

Nov 14, 2023

BUY
$36.46 - $44.03 $65,628 - $79,254
1,800 Added 7.59%
25,500 $974,000
Q2 2023

Aug 14, 2023

SELL
$30.28 - $38.74 $427,705 - $547,202
-14,125 Reduced 37.34%
23,700 $854,000
Q1 2023

May 15, 2023

BUY
$32.86 - $55.7 $70,747 - $119,922
2,153 Added 6.04%
37,825 $1.44 Million
Q4 2022

Feb 14, 2023

SELL
$40.06 - $59.44 $841,260 - $1.25 Million
-21,000 Reduced 37.06%
35,672 $2.03 Million
Q3 2022

Feb 14, 2023

BUY
$38.53 - $51.78 $1.98 Million - $2.67 Million
51,472 Added 989.85%
56,672 $2.24 Million
Q3 2022

Nov 14, 2022

BUY
$38.53 - $51.78 $2.18 Million - $2.93 Million
56,672 New
56,672 $2.24 Million
Q2 2022

Aug 15, 2022

SELL
$37.35 - $48.3 $194,220 - $251,159
-5,200 Closed
0 $0
Q1 2022

Feb 14, 2023

SELL
$31.97 - $41.06 $1.65 Million - $2.11 Million
-51,472 Reduced 90.82%
5,200 $207,000
Q1 2022

May 13, 2022

SELL
$31.97 - $41.06 $2.77 Million - $3.55 Million
-86,500 Reduced 94.33%
5,200 $207,000
Q4 2021

Feb 14, 2022

SELL
$31.82 - $40.75 $1.08 Million - $1.39 Million
-34,000 Reduced 27.05%
91,700 $3.69 Million
Q3 2021

Nov 15, 2021

BUY
$38.47 - $46.42 $4.84 Million - $5.83 Million
125,700 New
125,700 $5.11 Million
Q1 2021

May 14, 2021

SELL
$39.51 - $51.45 $3.47 Million - $4.52 Million
-87,900 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$25.81 - $43.62 $2.27 Million - $3.83 Million
87,900 New
87,900 $3.75 Million
Q4 2019

Feb 18, 2020

SELL
$14.93 - $19.53 $373,250 - $488,250
-25,000 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$15.2 - $17.69 $6.25 Million - $7.28 Million
-411,419 Reduced 94.27%
25,000 $388,000
Q2 2019

Aug 13, 2019

BUY
$14.75 - $17.26 $120,979 - $141,566
8,202 Added 1.92%
436,419 $7.5 Million
Q3 2018

Nov 08, 2018

BUY
$16.68 - $18.41 $618,961 - $683,158
37,108 Added 9.49%
428,217 $7.78 Million
Q2 2018

Aug 13, 2018

BUY
$16.87 - $20.3 $6.6 Million - $7.94 Million
391,109 New
391,109 $6.6 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.